Final Program

Microbiome 1

Emma Allen-Vercoe, University of Guelph - KEYNOTE
Bugs as drugs: microbial ecosystem therapeutics to treat gut dysbiosis

Mathieu Millette, Bio-K+ International Inc. - INVITED
Development of next-generation probiotics: bugs to tackle metabolic syndrome

Thomas A. Tompkins, Lallemand Health Solutions - INVITED
The impact of antibiotics and probiotics on the microbiome, resistome, and associated diarrhea

Lab / organ on a chip

Michael Shuler, Cornell University – KEYNOTE
Body on a chip systems to improve drug development

Margaret Magdesian, ANANDA Devices – INVITED
The future of drug development depends on more efficient in vitro models of human diseases

Nguyen-Vi Mohamed, McGill University – INVITED
Midbrain minibrains to study Parkinson's disease

Chengxi Cao, Shanghai Jiao Tong University
Mobile-like titration chip for visual POCT analysis of uric acid in urine of patient with tartaric disease via moving reaction boundary electrophoresis

Satoshi Yamaguchi, University of Tokyo
Photo-responsive cell immobilizing reagents for single-cell manipulation

Microbiome 2

Susannah Green-Tringe, DOE Joint Genome Institute – INVITED
Sequence-based interrogation of microbiomes

Julien Tremblay, National Research Council of Canada – INVITED
Systematic processing of microbiome genomics sequencing data

Abdoulaye Baniré Diallo, Université du Québec à Montréal – INVITED
Methods for real-time monitoring of pathogens

Microbiome 3

Charles Greer, National Research Council of Canada – INVITED
Advances in the analysis of microbiomes involved in biodegradation and remediation in the environment

Armand Séguin, Laurentian Forestry Centre – INVITED
Improving land restoration of sites impacted by natural resources exploitation through the study of soil and tree root-associated microbiomes

Trevor Charles, Waterloo - INVITED
Application of microbiome analysis to controlled environment agriculture

Nanobiotech 1

Paolo Scrimin, Università di Padova – INVITED
Gold nanoparticles: from protein recognition to protein mimicry

Sina Aghili, Ferdowsi University of Mashhad
Fe3O4 nanoparticles, magnetic properties, hydrothermal method, PbS/ZnS nanoparticles

Indranil Chakraborty, S. N. Bose National Centre for Basic Sciences
Design and development of bioactive a-hydroxy carboxylate group modified MnFe2O4 nanoparticle: comparative fluorescence study, magnetism and DNA nuclease activity

Mahsa Jalali, McGill University
Universal platform for detection of fluorescently labeled bacteria based on gold nanostructured shrub-like islands

Mohamed Ouqamra, Université de Montréal
Machine learning methods for single-molecule kinetics modelling: application to drifting time series from nanoelectronic sensors

Nanobiotech 2

Hanadi Sleiman, McGill University - KEYNOTE
DNA nanostructures for cellular administration of therapeutic agents

René Roy, Université du Québec à Montréal - KEYNOTE
New trends in nanoparticles syntheses and applications

Tamas Gorbe, Stockholm University
Development and applications of a Pd(0)-CalB CLEA bio-nano composite catalyst

Chunhua Yin, University of Science and Technology Beijing
Biosynthesis of ZnO nanoparticles for immobilization of Candida sp. lipase

Dalia Saldanha, McGill University
Engineered Curli based biomaterials for fluorescent sensing applications

Mariam Saad, McGill University
Generation of high-affinity aptamers binding to Legionella pneumophila

Artificial intelligence

Presented by the Government of Quebec Ministry of Economy, Science, and Innovation (MESI)

Sarah Jenna, My Intelligent Machines – INVITED
Talk title tba

Sonia Israel, AiFred – INVITED
Deep learning for precision psychiatry

Kam Kafi, Imagia – INVITED
Talk title tba

Jeremi Lavoie, Arctic Fox – INVITED
Optimization of MRI measurements pipeline for neurodegenerative diseases with deep learning

Protein structure and function

Romas Kazlauskas, University of Minnesota – INVITED
How hydroxynitrile lyases evolved from esterases

Guo-Chao Xu, Jiangnan University
Rewiring the substrate binding pockets of KpADH for stereocomplementary bioreduction of bulky-bulky ketones

Thales Paiva, Universidade Federal de Ouro Preto
Talin gene in Schistosoma mansoni: Gene expression and protein structure

Editha Renesteen, Universitas Indonesia
Characterization and transglycosylation activity of recombinant sucrose phosphorylase from Leuconostoc mesenteroides MBFWRS-3(1) expressed in E. coli

Feng Ni, National Research Council of Canada
Conformational stability and functional complexity of the novel granulin/epithelin modular (GEM) protein fold

Synthetic biology

Sylvain Moineau, Université Laval – KEYNOTE
CRISPR-Cas systems : from humble beginnings to today's headlines

Greg Stephanopoulos, MIT – KEYNOTE
Engineering microbes for industrial applications

Mike Pyne, Concordia University – INVITED
Debottlenecking benzylisoquinoline alkaloid biosynthesis in Saccharomyces cerevisiae

Vesta Korniakova, INRS-IAF
The fluoride riboswitch as a strategy for testing potent bacterial promoters while avoiding reporter gene toxicity

Abdel-Mawgoud Ahmad, MIT
Genome-wide efficient CRISPR/Cas9-mediated engineering of Yarrowia lipolytica

Antimicrobials and anti-infectives

Nancy Tawil, Phagelux - INVITED
Bacteriophages for the treatment of multi-drug resistant wound infections

Charlimagne Montealegre, Hong Kong University of Science and Technology
Antimicrobial efficacy of colloidal polymeric micelle solution against drug resistant nosocomial infections

Mandana Tavakolian, McGill University
Developing antibacterial nanocrystalline cellulose using natural antibacterial agents

Debajyoti Bose, Yobe State University
Antimicrobial potentials of Cuminum cyminum

Drug delivery and diagnostics 1

Karim Karim, University of Waterloo – INVITED
Real-time phase contrast X-ray imaging using a lab source for biotechnology applications

Bill Whitford, GE Healthcare – INVITED
Digital biomanufacturing will enable advanced theranostics

Melusine Bouchet, CRCHUM
Simple analytical model for the development of small-diameter vascular prostheses

Abdennour Abbas, University of Minnesota
Gold nanoplate-enhanced chemiluminescence for rapid microbial screening and detection

Stem cell technologies

Jane Lebkowski, Regenerative Patch Technologies – KEYNOTE
Development of pluripotent stem cell-based therapies for geographic atrophy

Anne Marinier, Université de Montréal – INVITED
Development of stem cell expanding molecules

Eric Jervis, StemCell Technologies
Optimized media and workflow for the expansion of human pluripotent stem cells as aggregates in suspension cultures

Abdolamir Allameh, Tarbiat Modares University
Targeted therapy of breast tumors in a mouse model by normal endothelial cells differentiated from mouse bone marrow mesenchymal stem cells

Small molecules and natural products 1

Yvan Guindon, Université de Montréal – INVITED
From bad to good : Free radical assisted development of anti cancer drugs

David Cotnoir-White, Université de Montréal
A new HTS approach to identify heterodimer selective rexinoids

Anupam Apoorva, Indian Institute of Technology Kharagpur
Stem extract of Basella alba with potential anticancer and antiangiogenic activity

Sourav Taru Saha, University of Witwatersrand
Delving KS-01 as a novel therapeutic strategy in treating breast cancer

Praveen Nekkar Rao, University of Waterloo   
Novel fused tricyclics as anti-Alzheimer's agents

Small molecules and natural products 2

Arjun Banskota, National Research Council of Canada
Anti-inflammatory activity of galactolipids isolated from marine and freshwater microalgae

Jessica Plescia, McGill University
Computationally-aided design and synthesis of dual covalent inhibitors for the treatment of cancer

Samuel Jacques, Université de Montréal
Synthetic natural products as a source of novel chemical matter for drug discovery

Ajay Babu Pazhayattil, Alphora Research Inc
Tools enabling small molecule development, qualification and commercialization lifecycle

Mihai Burai Patrascu, McGill University
A robust method for modeling the sugar puckering of nucleosides

Gene and cell therapy

Isabelle Rivière, Memorial Sloan Kettering Cancer Center – KEYNOTE
Advances in CAR-T cell therapy: the CD19 paradigm

Denis-Claude Roy, Centre de recherche Hopital Rosemont Maisonneuve – INVITED
Novel cellular approaches in the clinic to fight infections and leukemia

Jacques Tremblay, Université Laval – INVITED
CRISPR/Cas9 technology may be used to correct genes responsible for several monogenic hereditary diseases

Scott McComb, National Research Council of Canada
Use of CRISPR and fluorescent proteins to perform targeted in-frame knock-ins in mammalian cells

TBA

Antibody and protein therapeutics 1

John Babcook, Zymeworks – INVITED
Targeting tumors with bispecific antibodies and drug conjugates

Veronique Lecault, AbCellera – INVITED
Therapeutic antibody discovery: when the power of nature meets technology

Michel Gilbert, National Research Council of Canada
A novel glyco-engineering approach for site-specific conjugation

Francesco Lipari, Biotrial Bioanalytical Services
Generic ELISA processes to speed up the development of biotherapeutics

Antibody and protein therapeutics 2

Philippe Crine, PreciThera – INVITED
Design and development of asfotase alfa, the first bone-targeted enzyme replacement therapy

Maureen O'Connor, Formation Biologics – INVITED
Clinical and preclinical development of AVID100, an anti-EGFR antibody-drug conjugate

Mario Filion, Alethia Biotherapeutics – INVITED
Targeting EMT to treat advanced carcinomas with an anti-clusterin antibody

John Babcook, Zymeworks – INVITED
TBA

Brendan McConkey, University of Waterloo - INVITED
Using RNAseq data to compare biological response to MAb drug treatments

Drug delivery and diagnostics

Patricia Kitchen, Mundi Pharma – INVITED
Transdermal delivery of biologics

Heather Sheardown, McMaster University – INVITED
Changing the paradigms of drug delivery to the eye

Teodor Veres, National Research Council of Canada – INVITED
Microfluidic-based platforms for biological assays automation in life sciences research and remote medical applications

Hui Qian, National Research Council of Canada
The application of cryogenic transmission electron microscopy in drug delivery carriers

Vaccine technologies 1

Lorne Babiuk, University of Alberta – KEYNOTE
Enhancing vaccine efficacy through novel vaccines and delivery technology

Bassel Akache, National Research Council of Canada
Comparison of sulfated archaeal glycolipid archaeosomes with other immunological adjuvants in mice

Rong Gao, Sichuan University
Improvement of the immunity of mice to PRRS vaccine by porcine IL-23 gene encapsulated in Chitosan nanoparticles

Vaccine technologies 2

Helen Mao, CanSino – KEYNOTE
Development of a recombinant Ebola virus vaccine (Adenovirus type 5 vector）

Lakshmi Krishnan – INVITED
A vaccine candidate to protect Canadian Northern populations from Haemophilus influenzae A meningitis

Paul Rice, Biodextris
A case study in collaboration for early stage vaccine development

Wayne Conlan, National Research Council Canada
Advanced development of a novel live vaccine strain against tularemia

Teresa Zangirolami, Federal University of São Carlos
ClearColi as delivery platform for antigenic subunit pneumococcal vaccine

Hui Li, Sun Yat-sen University
Construction of shuffled polyvalent ompAs vaccines and immune protection and innate immune response against Vibrio alginolyticus and Edwardsiella tarda

Central nervous system diseases

Danica Stanimirovic, National Research Council of Canada – KEYNOTE
Addressing central nervous system target space using single-domain antibody technologies

Amanpreet Badhwar, McGill University - INVITED
Biomarkers - omics to imaging

Miroslava Cuperlovic-Culf, National Research Council of Canada
Metabolomics analysis and modeling for determination of significant processes in Alzheimer's disease development and diagnosis

Jeremiah Hadwen, University of Ottawa
Transcriptomic RNAseq drug screen in cerebrocortical cultures: towards novel neurogenetic disease therapies

Balu Chakravarthy, National Research Council of Canada
Development of a blood-brain barrier-crossing, amyloid-beta targeting peptide as a potential Alzheimer's disease therapeutic

Genetics and personalized medicine

Leo Wan, Ranomics – INVITED
Measuring the effect of genetic variation at splicing junctions using a high-throughput cellular fluorescence reporter system

Shirley Fenton, University of Waterloo – INVITED
Medtech and health informatics

Yifeng Li, National Research Council of Canada
Personalized prediction of genes with tumor-causing somatic mutations based on multi-modal deep Boltzmann machine

Ellen Feng, University of Calgary
Germline genomic patterns are associated with cancer risk, oncogenic pathways and clinical outcomes

Veronika Cencen, HKUST
Biotechnological strategies in treatment of obesity

S. Sadra Mirhendi, Memorial University
Discovering Type 1 Diabetes patient subgroups through integrative analysis of heterogeneous data

Amanda Gerges, CHU-Sainte-Justine
CARTaGENE, an open-access resource for genomic research in personalized medicine

Plant genomics

Jaroslav Dolezel, Institute of Experimental Botany - KEYNOTE
Chromosome genomics facilitates cloning genes and sequencing genomes

David Konkin, National Research Council of Canada - INVITED
Finding the variation that you were looking for: Advances in targeted sequencing strategies and their applications in gene discovery and breeding

Pierre Fobert, National Research Council of Canada - INVITED
Proof is in the pasta: application of high-throughput genotyping platform for the genetic improvement of Canadian wheat

Curt McCartney, Agriculture and Agri-Food Canada – INVITED
Targeting disease resistance genes in wheat

Youlian Pan, National Research Council of Canada
Fusarium head blight responsive transcriptional reprogramming in four wheat genotypes

Plant biotechnology

Holger Puchta, Karlsruhe Institute of Technology – INVITED
Gene editing in plants: Past, present, future

Pankaj Bhowmik, National Research Council of Canada – INVITED
Targeted mutagenesis in wheat microspores using CRISPR/Cas9

Sateesh Kagale, National Research Council of Canada – INVITED
Single cell genomic sequencing in plants: possibilities and limitations

John Laurie, Agriculture and Agri-Food Canada – INVITED
Non-transgenic efforts towards genome editing of plant zygotes and microspores

Somika Bhatnagar, Temasek LifeSciences Laboratory
Forest biotechnology: Development of sustainable tropical tree plantations for rapid and enhanced biomass production in Southeast Asia

Trevor Charles, University of Waterloo - INVITED
Talk title tba

Biomanufacturing and bioprocessing 1

Shou-Bai Chao, AstraZeneca BioVentures – KEYNOTE
Industry trends and future vision of biomanufacturing

Alaka Mullick, National Research Council of Canada – INVITED
Regulation of recombinant protein expression during CHO pool selection enhances the frequency of high-producing cells within the population

Mario Jolicoeur, École Polytechnique - INVITED
Towards an in silico platform for drug target identification and bioprocess optimization

Alexey Dudnik, Technical University of Denmark
Development of a plasmid toolbox for expression of long biosynthetic pathways in Lactococcus lactis

Biomanufacturing and bioprocessing 2

Marc Aucoin, University of Waterloo – INVITED
Enhancing insect cells as a cell culture platform by improving control over protein expression

Simon Joubert, National Research Council of Canada
High-throughput selection of high-producing CHO cell lines for biomanufacturing of biologics using our CHOBRI/rcTA platform

Marie-Anne Gauriat, National Research Council of Canada
Development and optimization of an industrial and scalable fermentation process for the production of recombinant CRM197 by E.coli

Charlimagne Montealegre, Hong Kong University of Science and Technology
Bacteriophage T3 inactivation during mixing

Tamer Salem, Zewail University of Science and Technology
Identifying the active sites of the OpIE2 promoter by tracking the EGFP activity driven by CMV/OpIE2 promoters located in tandem

Biomanufacturing and bioprocessing 3

Akihiko Kondo, RIKEN – INVITED
Development of super microbial cell factories for consolidated bioprocessing through synthetic bioengineering

Juan Asenjo, University of Chile – INVITED
The rational purification of proteins: proteomics, expert systems, modelling, process conditions and optimization

Boris Tartakovsky, National Research Council of Canada
On-line monitoring and diagnostics of bioprocesses using multi-wavelength fluorometry

Teresa Zangirolami, Federal University of São Carlos  
Bioreactor control based on metabolic fluxes: enhancing bioethanol production in micro-aerated conditions

Biomaterials and bioproducts 1

Wei Zhang, Flinders University - KEYNOTE
Marine biotechnology: an ocean of opportunities toward the blue bioeconomy

Ulla Moilanen, Häme University of Applied Sciences
Isolation of collagen from fish and chicken bones with pressurized hot water extraction

Laura Carmona Saldarriaga, Universidad EAFIT
Projections for the production of enzymes of industrial interest by Humphreya coffeata

Sarvesh Kumar Srivastava, DTU Nanotech
Biogenic materials for health, energy and environment

Abdul Mazid, University of Dhaka
Proteases producing indigenous Bacillus species as a source of novel thrombolytic and fibrinolytic agents

Biomaterials and bioproducts 2

Fengwu Bai, Shanghai Jiao Tong University – INVITED
Challenges and strategies for solutions with biomanufacture: from bulk commodities to value-added products

Donald Smith, McGill University – INVITED
Development and deployment of biologicals for a sustainable and climate change resilient bioeconomy

Spiros Agathos, Yachay Tech University – INVITED
Biosustainability: from pure strains and biocatalysts to managed microbial communities

Fatemeh Goodarzi, Memorial University
Molecular dynamic simulation of water oil emulsion stability: effect of emulsifier and temperature

André Freches, LAQV-REQUIMTE, FCT NOVA
Microbial conversion of forest wastes into value-added polyhydroxyalkanoates

Bioremediation and wastewater treatment 1

Eugenia J. Olgiun, INECOL – KEYNOTE
Aquatic phyto remediation technologies: potential and research opportunities

Louis-B. Jugnia, National Research Council of Canada
In situ enhanced bioremediation treatability study of RDX contaminated soil and groundwater at a former military demolition range

Pierre-Olivier Gendron, Agnico Eagle Mines limited
Denitrification within moving-bed biofilm Reactors (MBBR) using nitrogen contaminants discharged from a gold mine operation: From pilot to full scale

Kashif Rasool, Qatar Environment and Energy Research Institute
Sulfate reducing bacteria biofilm growth inhibition in inject sea water by green zinc oxide interlinked chitosan nanoparticles

Haiyang Zhang, University of Science and Technology Beijing 
Structural basis of microcystinase activity for biodegrading cyclic-peptide hepatotoxins

Bioremediation and wastewater treatment 2

Philippe Corvini, University of Applied Sciences and Arts Switzerland – INVITED
Bacteria making a meal of pharmaceuticals

Xiaolu Liu, University of Science and Technology Beijing
Determine mechanistic causes for antagonism in PAH mixture degradation in Mycobacterium species

Qianqian Xu, University of Science and Technology Beijing
Cloning and expression of first gene for biodegrading nodularin by Sphingopyxis sp. USTB-05

Wei Han, Hong Kong University of Science and Technology
Ionic liquid-based air purification systems for the removal of bioaerosols and molecular pollutants

Khaled Mahmoud, Qatar Energy and Environment Research Institute
Green nanocomposites for the efferent inhibition of sulfate-reducing bacteria (SRB) biocorrosion on carbon steel

Tayssir Guedri, INRS-ÉTÉ
Nanoencapsulation and release study of enzymes from Alkanivorax borkumensis in chitosan-tripolyphosphate formulation

Algal technologies 1

Stephen O'Leary, National Research Council Canada – Session chair

Satu Nokkonen, Häme University of Applied Sciences
Utilization of dairy side-stream in microalgae cultivation

Lizzette Moreno-Garcia, McGill University
Biomass production and nutrients removal by a consortium of microalgae and bacteria grown on wastewaters

Jose Osvaldo Beserra Carioca, UFC
Algal biorefinery to treat fish processing effluents using microalgae to produce reclaimed water and added value products

Adrian Unc, Memorial University
The ecological context of microbial-microalgal cultures and its management significance  

Algal technologies 2

Eugenia J. Olgiun, INECOL – INVITED
Wastewater treatment and production of biofuels and microalgae enriched in lipids or carbohydrates within an integrated biorefinery

Patrick McGinn, National Research Council of Canada
Bioprospecting for microalgae strains with commercial applications

Grant Allen, University of Toronto
Enhancing the delivery of light to algal biofilms using a waveguide biofilm photobioreactor

Valerie Ward, University of Waterloo
Fractionation of microalgae biomass using ionic liquids: a promising technology for the microalgae biorefinery

Pascale Champagne, Queen's University
Production of biofuel precursors from algal carbohydrates via 5-hydroxymethyl furfural pathways using biphasic reactions and high pressure CO₂

Biofuels and bioenergy 1

Lisbeth Olsson, Chalmers University of Technology - KEYNOTE
From understanding natural enzyme action on lignocellulose to its exploration in material biorefineries

David Bressler, University of Alberta – INVITED
Advanced approaches to biofuels and co-products

Zhanying Liu, Inner Mongolia University of Technology
Improve lignocellulose degradation ratio and ethanol titer of corn straw and Salix psammophila by 1-ethyl-3-methyl imidazolium diethylphosphate pretreatment

Karolin Dietrich, McGill University
681-Integrated wood biorefineries for the production of the compostable biopolymer polyhydroxybutyrate (PHB): Difference of sugar and inhibitor consumption of a hardwood and a softwood hydrolysate

Biofuels and bioenergy 2

Jack, Saddler, University of British Columbia – KEYNOTE
Forest residues-to-drop in/biojet fuels

Rachel Murdy, Lallemand – INVITED
Advanced yeast strain development for fuel ethanol fermentation

Xinqing Zhao, Shanghai Jiao Tong University  
Exploration of novel genes involved in protein production and secretion by Saccharomyces cerevisiae through mining genes related to environmental stress tolerance

Shaghayegh Ostadjoo, McGill University         
Mechanoenzymatic hydrolysis of xylan

Ruxandra Cimpoia, National Research Council of Canada        
Anaerobic digestion sludge community's tolerance to impurities and by-products presents in syngas

Biofuels and bioenergy 3

Murray Moo-Young, University of Waterloo – KEYNOTE
Biofuels: future techno-economic challenges

Chen-Guang Liu, Shanghai Jiao Tong University
Redox potential regulation strategies improve Saccharomyces cerevisiae tolerance to furfural

Fabien Hammerer, McGill University
Solvent-free enzymatic activity: a high yielding approach to cellulose digestion

Sadegh Papari, Memorial University
Study of fractional condensation for sawmill residues pyrolysis oil vapours

The How's and Why's of Commercializing Canadian Innovation for a Global Market

Moderator: Andrew Casey, President and Chief Executive Officer, BIOTECanada

Panelists:

Anthony Cheung
President and Chief Executive Officer, enGene
Montréal, Canada

Donald Olds
President and CEO, NEOMED
Montréal, Canada

Steve Xanthoudakis
Chief Business Officer, CQDM
Montréal, Canada

Patenting and commercializing university biotechnology innovations

Moderator: Carmela De Luca, Partner, Bereskin & Parr

Panelists:

Johanne Kaplan
Chief Development Officer, ProMIS Neurosciences
Boston, United States
Presentation: Turning academic discoveries into drugs: An industry perspective on the importance of intellectual property

Serge Lapointe
Partner and Patent Agent, Fasken
Montréal, Canada
Presentation: Patent, publish and prosper! Academic research from the point of view of a patent agent

Neena Kushwaha
Associate Director, Patent Branch, Canadian Intellectual Property Office
Ottawa, Canada
Presentation: Connecting the dots: Linking clients with intellectual property resources

Quebec industrial biotech showcase

Presented by: Government of Quebec Ministry of Economy, Science, and Innovation

Moderated by: TBA, Consortium de recherche et d'innovation en bioprocédés industriels au Québec (CRIBIQ)

Panelists:

Laurent Bernier
Senior Vice-President, Compliance and Administration, BioAmber
Montreal, Québec
Green chemistry: Harnessing opportunities and overcoming barriers to success

Laura Boivin
Owner and President, Fumoir Grizzly
Québec City, Canada
Presentation title TBA

TBA

Innovative production technologies

Moderator: Timothy Smith, President and Chief Executive Officer, Octane Medical Group

Panelists:

James Piret
Professor, Chemical and Biological Engineering
University of British Columbia
Vancouver, Canada
Presentation: Technologies tailored to address cell therapy bioprocess challenges

Rénald Gilbert
Program Leader (interim), Vaccines and Immunotherapeutics
National Research Council of Canada
Montréal, Canada
Presentation: Viral vector production for cell and gene therapy

Alain Doucet
Scientist, Development of new processes
Medicago
Québec City, Canada
Presentation: Transforming the approach to vaccines and protein-based therapeutics

Success stories in Canadian biomanufacturing

Presented by: FujiFilm Diosynth

Moderator: FujiFilm Dyosynth

Panelists:

David Poon
Executive Director, External R&D and Alliances
Zymeworks
Vancouver, Canada
Presentation: The Zymeworks journey: From computational modeling to clinical development

Allison Hagerman
Vice-President, Product Development
Oncolytics
Calgary, Canada
Presentation: It takes more than just good data - Validation of a reovirus production process

Andrew Booth
Chief Commercial Officer
Stem Cell Technologies
Vancouver, Canada
STEMCELL Technologies: The future of Canada's largest biotech company

Successes and challenges from bioeconomies around the world

Moderated by: GE Healthcare

Panelists:

Shay Power
Vice-President of Life Sciences, IDA Ireland
Dublin, Ireland
Presentation: The grass is greener in Ireland: Incentives to build a world-class bioeconomy

Frank Van Lier
Director of R&D, Bioprocess Engineering
National Research Council of Canada
Montréal, Canada
Presentation: Canadian consultation on biomanufacturing

Followed by two Canadian case studies:

Dina Iezzi
Director, Marketing & Special Projects
Therapure Biopharma
Mississauga, Canada
Canadian Case Study 1: Therapure Biopharma

Molly McGlaughlin
Director, Strategy and Business Development, Biologics
BioVectra
Charlottetown, Canada
Canadian Case Study 2: BioVectra

Christelle Fasano
Director, Business Development, Life Sciences and Health Technologies
Montréal International
Montréal, Canada
Biomanufacturing: Québec's top priority in life sciences

Registration

Presentations by invited experts in various biotechnology-related fields, and in-depth panel discussion

OPENING REMARKS: Dr. Reza Salavati 
Biotechnology Graduate Programs Director

KEYNOTE:  Senator Rosa Galvez, PhD. 

Gordon C. McCauley
President & CEO at CDRD

Mr. Phu Vinh On, MSc.
Associate Director of Pricing Strategy, ​Negotiations and Contracting at Merck Canada 

Dr. Robert Déziel, PhD., MBA
Quebec Regional Office Manager, NSERC

Mr. Charles Fracchia, MSc.
Founder & CEO of BioBright

Danièle Éthier
Partner at ROBIC
Biochemist and Patent Agent in Canada and in the US

, MSc., MBA
CEO at BIOGENIQ

Adjunct Professor of Pharmacology and Therapeutics in the Faculty of Medicine at McGill University

Networking cocktail